Poll: Younger people more open to using genetics to increase fertility and reduce chances of inherited diseases 

IVF Rex

Our report Fertility, Embryo Research and Genome Editing: Public Attitudes in Europe explores public attitudes to fertility treatment,  embryo research, genome editing, donor conception, surrogacy and related topics in four European countries – the UK, the Netherlands, Spain and Italy.

…

In all four of the countries surveyed, a majority of respondents … answered either ‘Yes, definitely’ or ‘Yes, probably’ when asked whether the state should fund fertility treatment for people who are infertile and wish to conceive.

A substantial proportion of respondents in all four of the countries surveyed … did not support people undergoing private fertility treatment being able to choose the biological sex of their child …

However, younger respondents … were more likely than older respondents to say that sex selection should be permitted.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

The survey asked respondents whether they supported or opposed the use of genome editing in human embryos, in the following three scenarios.

  • In human embryos for scientific and medical research, to help understand or develop treatments for congenital disease. …
  • In human embryos that will be transferred to a human womb to establish pregnancy, to help eliminate a severe or life-threatening condition – such as cystic fibrosis ….
  • In human embryos that will be transferred to a human womb to establish pregnancy, to help eliminate a common, medically manageable condition – such as asthma ….

In all four of the countries surveyed, more respondents supported than opposed the use of genome editing in human embryos in all three of these scenarios.

This is an excerpt. Read the original post here

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Sep-2-2026-02_03_32-PM
How much of a problem is AI’s water use?
ChatGPT-Image-Aug-26-2026-12_46_16-PM
Viewpoint: The fake controversy over whether combining childhood vaccines is dangerous— a debate science resolved 25 years ago
ChatGPT-Image-Sep-22-2026-10_32_46-AM
There has been a slew of recent reports of food recalls and foodborne outbreaks. Do we face an escalating problem?
ChatGPT-Image-Sep-21-2026-03_41_02-PM
Viewpoint: Does IQ really measure intelligence? BBC gets it wrong.
ChatGPT-Image-Sep-18-2026-01_38_09-PM
Microsoft exec: AI is a ‘doom loop’ scraping the ‘largest theft of labor in human history'
Screenshot-2026-09-17-at-12.00.30-PM
Investigative group ProPublica finds links between ectopic pregnancy deaths and abortion bans
Screenshot-2026-09-17-at-1.07.08-PM
'We are dangerously addicted to antidepressants': Should we heed RFK Jr.’s sobering warning?
Screenshot-2026-09-23-at-11.55.01-AM
How can we know if social media bans actually help teens?
ChatGPT-Image-Sep-23-2026-11_47_32-AM
Facing pressure from Trump administration, fewer hospitals offer medical treatment for transgender minors
Screenshot-2026-09-16-at-3.14.20-PM
19%: Plunging support for Trump-RFK, Jr. measles vaccine safety oversight
ChatGPT-Image-Sep-17-2026-12_28_43-PM
Vitamin D, omega-3 fish oil and glucosamine supplements could cause brain damage 
Screenshot-2026-09-16-at-2.26.42-PM
Viewpoint: How to ecologically damage America’s forests: Ban glyphosate
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.